Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-02-16
1997-11-11
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 19, 530331, 562444, 562445, A61K 3805, A61K 3806, C07K 500
Patent
active
056864230
ABSTRACT:
A series of di- and tri-peptide mimetic dopamine prodrugs are synthesized in which D-phenylglycine or D-p-hydroxyphenylglycine is attached as tools for delivery of L-dopa through the intestine via the intestinal dipeptide-mediated carrier transport system. These compounds are found useful as an active ingredient for the treatment of Parkinson's disease.
REFERENCES:
CA: 123(21): 286619P (Wang et al., Chin. Pharm. J. (Taipei) 1995 47(1) 47-58.
CA: 77(7): 62317G (Felix et al., De 2153813 1972).
Nakonteczna et al., Liebiss Ann. Chem. (Oct., 1994) 1055-1058.
Felix et al., J. Med. Chem. vol. 17 No. 4 (1974) 422-426.
Amidon et al., "Absorption of Peptide and Peptidomimetic Drugs", Annu. Rev. Pharmacol. Toxicol. 34;321-341, 1994.
Bai et al., "Structural Specificity of Mucosal-Cell Transport and Metabolism of Peptide Drugs: Implication for Oral Peptide Drug Delivery", Pharmaceutical Research 9:969-978, 1992.
Hu et al., "Use of the Peptide Carrier System to Improve the Intestinal Absorption of L-.alpha.-Methyldopa: Carrier Kinetics, Intestinal Permeabilities, . . . ", Pharmaceutical Research 6:66-70, 1989.
Hu Oliver Yoa-Pu
Lee Jia-Shuai
Lu Hsiao-Hwa
Luo Wen-Lin
Tsai Ming-Cheng
Celsa Bennett
Department of Health, the Executive Yuan, Republic of China
Tsang Cecilia J.
LandOfFree
Di-and tri-peptide mimetic compounds for Parkinson's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Di-and tri-peptide mimetic compounds for Parkinson's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Di-and tri-peptide mimetic compounds for Parkinson's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1229174